-
【GE CHENG News】Avanci launches a patent pool for the "aftermarket installed products" with OPPO, ZTE, etc. becoming licensors
2025-05-07Avanci, a patent licensing platform for the automotive Internet of Things (IoT), recently announced the launch of a patent licensing program for the automotive aftermarket (Avanci Aftermarket), which provides licenses for connected devices that are installed after the vehicle is sold, including equi -
【GE CHENG News】Audi v. NIO trademark infringement case: NIO succeeds in appeal, Audi’s request is rejected
2025-05-07Audi filed a lawsuit against NIO in Munich, Germany, accusing NIO ES6 and ES8 of being too close to the Audi S6 and S8, alleged trademark infringement. In the first instance, the Munich District Court sentenced in favor of Audi.At that time, a German court judge explained that although the names of -
【GE CHENG News】The upgraded Memorandum of Understanding between the CNIPA and the Iranian Intellectual Property Authority signed in Beijing
2025-05-07In the afternoon of February 14th, witnessed by Chinese President Xi Jinping and Iranian President Rahim, CNIPA signed the upgraded version of the "Memorandum of Understanding with the Intellectual Property Center of the Contract and Property Registration Office of the Islamic Republic of Iran" in t -
【GE CHENG News】The number of valid invention patents in China reaches 4.212 million
2025-05-07It is reported recently that in 2022, a total of 798,000 invention patents and 6.177 million registered trademarks were authorized in China. By the end of 2022, the number of effective invention patents in China has reached 4.212 million, and the number of high-value invention patents per 10,000 peo -
【GE CHENG News】Yiling Pharmaceutical's new patent against Delta virus strain is announced
2025-05-07On February 10, the patent "Application of a Traditional Chinese Medicine Composition in the Preparation of Anti-New Coronavirus Delta Variant Strain Drugs" is announced, which is applied by Hebei Yiling Pharmaceutical Research Institute Co., Ltd., a wholly-owned subsidiary of Yiling Pharmaceutical.